Operator: Good afternoon. My name is Kathy, and I ll be your conference operator for today. At this time, I would like to welcome everyone to the Relmada Therapeutics, Inc.
Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Relmada Therapeutics, Inc. (Nasdaq: RLMD) ("Relmada," the "Company," "we," "us, "our"), a late-stage biotechnology company addressing diseases.
/PRNewswire/ Relmada Therapeutics, Inc. (Nasdaq: RLMD) ("Relmada," the "Company," "we," "us, "our"), a late-stage biotechnology company addressing diseases.
Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial - read this article along with other careers information, tips and advice on BioSpace